33rd week of 2016 patent applcation highlights part 8 |
Patent application number | Title | Published |
20160235693 | COMPOSITIONS, METHODS AND USES FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS BY CONTROLLING BLOOD GLUCOSE LEVEL | 2016-08-18 |
20160235695 | COMBINATION COMPOSITION | 2016-08-18 |
20160235696 | MODIFICATION OF THE PH AND OTHER PHYSICAL PROPERTIES OF OXALOACETIC ACID TO ALLOW FOR ENHANCED STABILITY AND MULTIPLE DELIVERY SYSTEMS | 2016-08-18 |
20160235697 | GINGER METABOLITES AND USES THEREOF | 2016-08-18 |
20160235698 | COMPOSITIONS AND METHOD FOR DESTABILIZING, ALTERING, AND DISPERSING BIOFILMS | 2016-08-18 |
20160235699 | COMPOSITIONS COMPRISING CITRULLINE AND LEUCINE AND THEIR USE IN THE TREATMENT OF DIABETES AND METABOLIC SYNDROME | 2016-08-18 |
20160235700 | GRANULAR FEED SUPPLEMENT | 2016-08-18 |
20160235701 | Composition and Methods for Treating Intestinal Hyperpermeability | 2016-08-18 |
20160235702 | METHODS FOR IMPROVING JOINT FUNCTION | 2016-08-18 |
20160235703 | Novel Uses of Neuraminidase Inhibitors in Infectious Diseases | 2016-08-18 |
20160235704 | ANTIMICROBIAL TITANIUM DIOXIDE NANOPARTICLES FUNCTIONALIZED WITH CATIONIC SILVER IONS | 2016-08-18 |
20160235705 | MULTI-ARM POLYMERIC PRODRUG CONJUGATES OF TAXANE-BASED COMPOUNDS | 2016-08-18 |
20160235706 | INDANYLOXYDIHYDROBENZOFURANYLACETIC ACIDS | 2016-08-18 |
20160235707 | DISUBSTITUTED BETA-LACTONES AS INHIBITORS OF N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) | 2016-08-18 |
20160235708 | TOPICAL PIGMENTORY COMPOSITION | 2016-08-18 |
20160235709 | LIMITED RELEASE LINGUAL THIOCTIC ACID DELIVERY SYSTEMS | 2016-08-18 |
20160235711 | AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS | 2016-08-18 |
20160235712 | CANCER TREATMENT METHOD | 2016-08-18 |
20160235713 | AUTOTAXIN INHIBITOR COMPOUNDS | 2016-08-18 |
20160235714 | ENZALUTAMIDE IN COMBINATION WITH AFURESERTIB FOR THE TREATMENT OF CANCER | 2016-08-18 |
20160235715 | Pasty Bio-Adhesive Sustained Release Compositions | 2016-08-18 |
20160235716 | SPIROCYCLIC HAT INHIBITORS AND METHODS FOR THEIR USE | 2016-08-18 |
20160235717 | BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS | 2016-08-18 |
20160235718 | COMPOUNDS AND METHODS FOR TREATING AN EPILEPTIC DISORDER | 2016-08-18 |
20160235719 | METHOD FOR TREATING DEMENTIA | 2016-08-18 |
20160235720 | Long-Acting Spiro-Isoxazoline Formulations | 2016-08-18 |
20160235721 | BENZOHETEROCYCLIC COMPOUNDS AND USE THEREOF | 2016-08-18 |
20160235722 | Stable Solid Immunosuppressor Composition | 2016-08-18 |
20160235723 | BREAST CANCER CELL GROWTH-INHIBITING ENZYME INHIBITORS, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF | 2016-08-18 |
20160235724 | TETRAHYDROPYRIDOETHERS FOR THE TREATMENT OF STARGARDT'S DISEASE | 2016-08-18 |
20160235725 | TREATMENT FOR CHEMOTHERAPY-INDUCED COGNITIVE IMPAIRMENT | 2016-08-18 |
20160235726 | Controlled Delivery System | 2016-08-18 |
20160235727 | NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS | 2016-08-18 |
20160235728 | APOPTOSIS SIGNAL-REGULATING KINASE INHIBITOR | 2016-08-18 |
20160235729 | 2,4-THIAZOLIDINEDIONE DERIVATIVES IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | 2016-08-18 |
20160235730 | METHODS TO INDUCE TARGETED PROTEIN DEGRADATION THROUGH BIFUNCTIONAL MOLECULES | 2016-08-18 |
20160235731 | METHODS TO INDUCE TARGETED PROTEIN DEGRADATION THROUGH BIFUNCTIONAL MOLECULES | 2016-08-18 |
20160235732 | METHODS AND COMPOSITIONS FOR REDUCTION OF SIDE EFFECTS OF THERAPEUTIC TREATMENTS | 2016-08-18 |
20160235733 | FORMULATIONS and PHARMACOKINETICS OF DEUTERATED BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 | 2016-08-18 |
20160235734 | COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY | 2016-08-18 |
20160235735 | TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND FAMPRIDINE | 2016-08-18 |
20160235736 | ANTIMICROBIAL COMPOSITIONS | 2016-08-18 |
20160235737 | MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS | 2016-08-18 |
20160235738 | Buprenorphine-wafer for drug substitution therapy | 2016-08-18 |
20160235739 | BUPRENORPHINE WAFER FOR DRUG SUBSTITUTION THERAPY | 2016-08-18 |
20160235740 | Compositions of (-)-17-(Cyclobutylmethyl)Morphinan-3,14,-Diol | 2016-08-18 |
20160235741 | METHOD FOR TREATING HYPERTENSION | 2016-08-18 |
20160235742 | SPRAY DRY FORMULATIONS | 2016-08-18 |
20160235743 | NON-PLATINUM-BASED ANTI-CANCER COMPOUNDS FOR USE IN TARGETED CHEMOTHERAPY | 2016-08-18 |
20160235744 | SUBSTITUTED PYRIDO[2,3-b]PYRAZINES AS FGFR KINASE INHIBITORS | 2016-08-18 |
20160235745 | METHODS OF TREATING DIABETES OR OBESITY USING BILE ACIDS, BILE SALTS, AND MIMICS THEREOF | 2016-08-18 |
20160235746 | Novel Amino Pyrimidine Derivatives | 2016-08-18 |
20160235747 | FBXO3 INHIBITORS | 2016-08-18 |
20160235748 | PYRAZOLO[1,5-A]PYRIMIDINES AS ANTIVIRAL AGENTS | 2016-08-18 |
20160235749 | MICRO-PARTICULATED NANOCAPSULES CONTAINING LOPINAVIR WITH ENHANCED ORAL BIOAVAILABILITY AND EFFICACY | 2016-08-18 |
20160235750 | SMALL MOLECULES TARGETING HIV-1 NEF | 2016-08-18 |
20160235751 | FORMULATIONS OF 5-FLUOROCYTOSINE AND USES THEREOF | 2016-08-18 |
20160235752 | COMPOSITIONS, METHODS OF USE, AND METHODS OF TREATMENT | 2016-08-18 |
20160235753 | THERAPEUTIC COMPOUNDS AND USES THEREOF | 2016-08-18 |
20160235754 | HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS | 2016-08-18 |
20160235755 | HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK | 2016-08-18 |
20160235756 | 4-[5-(3-CHLORO-PHENOXY)-OXAZOLO[5,4-D]PYRIMIDIN-2-YL]-2,6-DIMETHYL-PHENOXY- }-ACETIC ACID FOR USE IN THE PREVENTION OR TREATMENT OF ACUTE KIDNEY INJURY | 2016-08-18 |
20160235757 | ICOTINIB-CONTAINING TOPICAL SKIN PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | 2016-08-18 |
20160235758 | COMBINATION OF MTOR INHIBITORS AND PI3-KINASE INHIBITORS, AND USES THEREOF | 2016-08-18 |
20160235760 | METHODS OF TREATMENT USING SELECTIVE BCL-2 INHIBITORS | 2016-08-18 |
20160235761 | THERAPEUTIC COMPOUNDS AND USES THEREOF | 2016-08-18 |
20160235762 | 7-AMINOCEPHALOSPORANIC ACID DERIVATIVE AS INHIBITOR OF IL-15 AND IL-2 ACTIVITY | 2016-08-18 |
20160235763 | USE OF REDD1 INHIBITORS TO DISSOCIATE THERAPEUTIC AND ADVERSE ATROPHOGENIC EFFECTS OF GLUCOCORTICOID RECEPTOR AGONISTS | 2016-08-18 |
20160235764 | Oral Transmucosal Drug Delivery System | 2016-08-18 |
20160235765 | Methods of Managing Eye Pain and Compositions Related Thereto | 2016-08-18 |
20160235766 | PROPELLANT-FREE TOPICAL SPRAY COMPOSITION OF HALOBETASOL | 2016-08-18 |
20160235767 | TOPICAL FORMULATIONS COMPRISING A STEROID | 2016-08-18 |
20160235768 | TOPICAL FORMULATIONS COMPRISING A STEROID | 2016-08-18 |
20160235769 | COMPOSITIONS FOR THE TREATMENT OF INFLAMMATION OF THE GASTROINTESTINAL TRACT | 2016-08-18 |
20160235770 | METHODS OF USE TO ORALLY AND TOPICALLY TREAT ACNE AND OTHER SKIN CONDITIONS BY ADMINISTERING A 19-NOR CONTAINING VITAMIN D ANALOG WITH OR WITHOUT A RETINOID | 2016-08-18 |
20160235771 | METHOD OF REDUCING MULTI-DRUG RESISTANCE USING INOSITOL TRIPYROPHOSPHATE | 2016-08-18 |
20160235772 | Dosage Forms for Oral Administration of Zoledronic Acid or Related Compounds for Treating Disease | 2016-08-18 |
20160235773 | ANTIDEPRESSANT COMBINATION DRUG | 2016-08-18 |
20160235774 | ANTI-BACTERIAL APPLICATIONS OF POLY-N-ACETYLGLUCOSAMINE NANOFIBERS | 2016-08-18 |
20160235775 | Mannose Derivatives for Treating Bacterial Infections | 2016-08-18 |
20160235776 | SUSTAINED-RELEASE COMPOSITIONS COMPRISING TOPIRAMATE AND AN ALKALIZER | 2016-08-18 |
20160235777 | USE OF BAICALIN IN PREPARATION OF DRUGS FOR TREATING ACUTE HEMOLYTIC UREMIC SYNDROME | 2016-08-18 |
20160235778 | COMPOSITIONS CONTAINING PUFA, URIDINE AND CHOLINE AND METHODS OF USE THEREOF | 2016-08-18 |
20160235779 | TREATMENT OF CANCERS AND HEMATOPOIETIC STEM CELL DISORDERS PRIVILEGED BY CXCL12-CXCR4 INTERACTION | 2016-08-18 |
20160235780 | EYE DROP FORMULATION WITH ENHANCED PROPERTIES BY COMBINING SODIUM HYALURONATE WITH CARBOXYMETHYLCELLULOSE | 2016-08-18 |
20160235781 | DIURETIC INDUCED ALTERATIONS OF PLASMA VOLUME | 2016-08-18 |
20160235782 | SODIUM THIOSULFATE-CONTAINING PHARMACEUTICAL COMPOSITIONS | 2016-08-18 |
20160235783 | ENCODED BIOELECTRONIC METHOD AND SYSTEM AND CALCIUM TREATMENT FOR SLAYING CANCER BY RAPID TRIGGERING OF CELLULAR APOPTOSIS AND KARYORRHEXIS | 2016-08-18 |
20160235784 | METHOD FOR TREATING ITCH | 2016-08-18 |
20160235785 | SOLID DIALYSIS A AGENT CONTAINING ALKALI METAL DIACETATE, AND TWO-PART TYPE LOW-ACETATE DIALYSIS AGENT USING SAME | 2016-08-18 |
20160235786 | FORMULATION, APPARATUS, AND METHODS FOR TREATMENT OF BRAIN TRAUMA | 2016-08-18 |
20160235787 | Epitope Spreading Associated with CAR T-Cells | 2016-08-18 |
20160235788 | STEM CELL MICROPARTICLES AND miRNA | 2016-08-18 |
20160235789 | Bone Marrow Origin Progenitor Cell or Endothelial Progenitor Cell in Combination with DNMT1 Gene Therapy for Vascular Repair in Metabolic Disease | 2016-08-18 |
20160235790 | THERAPY WITH CELLS FROM HUMAN PLACENTA AND HEMATOPOIETIC CELLS | 2016-08-18 |
20160235791 | BACTERIA OF THE STENOTROPHOMONAS GENUS AND/OR GROWTH INDUCER OF SAID BACTERIA FOR PREVENTING AND/OR TREATING ATOPIC DERMATITIS | 2016-08-18 |
20160235792 | PROBIOTIC AND PREBIOTIC COMPOSITIONS, AND METHODS OF USE THEREOF FOR TREATMENT AND PREVENTION OF GRAFT VERSUS HOST DISEASE | 2016-08-18 |
20160235793 | Immuno-Oncolytic Therapies | 2016-08-18 |
20160235794 | LIPID EXTRACT OF PASSIFLORA SEEDS | 2016-08-18 |
20160235795 | THERAPY FOR PROMOTING CELL GROWTH | 2016-08-18 |